IRIS PubliCatt

Rocca, Bianca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.088
NA - Nord America 3.873
AS - Asia 1.327
AF - Africa 57
SA - Sud America 57
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.434
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.832
DE - Germania 1.159
SE - Svezia 780
CN - Cina 567
UA - Ucraina 503
IT - Italia 489
SG - Singapore 330
IE - Irlanda 281
FR - Francia 257
ID - Indonesia 167
GB - Regno Unito 131
PL - Polonia 112
FI - Finlandia 110
RU - Federazione Russa 102
IN - India 87
TR - Turchia 66
BE - Belgio 34
ES - Italia 31
AU - Australia 28
CA - Canada 24
CZ - Repubblica Ceca 24
IR - Iran 23
CI - Costa d'Avorio 22
AR - Argentina 18
HK - Hong Kong 18
NL - Olanda 18
JP - Giappone 17
MX - Messico 17
BR - Brasile 15
ET - Etiopia 14
KR - Corea 13
CH - Svizzera 12
CO - Colombia 10
AT - Austria 9
EG - Egitto 7
PH - Filippine 7
MK - Macedonia 6
CL - Cile 5
GR - Grecia 5
PE - Perù 5
TW - Taiwan 5
ZA - Sudafrica 5
GH - Ghana 4
IL - Israele 4
NO - Norvegia 4
RO - Romania 4
VN - Vietnam 4
DK - Danimarca 3
IQ - Iraq 3
LT - Lituania 3
MT - Malta 3
PK - Pakistan 3
PT - Portogallo 3
BJ - Benin 2
KW - Kuwait 2
LV - Lettonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
VE - Venezuela 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BO - Bolivia 1
EC - Ecuador 1
EU - Europa 1
HU - Ungheria 1
IM - Isola di Man 1
KE - Kenya 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 9.434
Salva come PNG Salva come JPEG
Città #
Chandler 658
Ashburn 468
Dublin 275
Jacksonville 255
Singapore 239
San Mateo 225
Jakarta 165
Wilmington 163
Nanjing 151
Woodbridge 120
Ann Arbor 106
Warsaw 105
Houston 93
Lawrence 92
Cattolica 88
Rome 83
Boston 80
Milan 77
Dearborn 71
Fairfield 70
Beijing 69
Moscow 65
New York 63
Nürnberg 59
Redwood City 59
Princeton 53
Seattle 52
Los Angeles 49
Izmir 46
Chicago 40
Nanchang 38
Munich 35
Mountain View 32
Shenyang 32
Tianjin 29
Brussels 26
University Park 26
Redmond 25
Boardman 24
Hebei 24
Zhengzhou 24
Bremen 23
Hangzhou 23
Abidjan 22
Brno 22
Kunming 22
Pune 20
Detroit 19
Shanghai 18
Bareggio 17
Cambridge 17
Federal 16
Hounslow 16
Mexico 16
Tobarra 16
Wayne 16
Busto Arsizio 15
Fremont 15
Leawood 15
Marseille 15
Augusta 14
Norwalk 14
Washington 13
Hong Kong 12
Jiaxing 12
London 11
Lancaster 10
Simi Valley 10
Andover 9
Changsha 9
Falls Church 9
Lanzhou 8
Ottawa 8
Bursa 7
Edinburgh 7
Guangzhou 7
Helsinki 7
Quezon City 7
Vienna 7
Ardabil 6
Florence 6
Hefei 6
Kish 6
Kraków 6
Latham 6
Padova 6
Prilep 6
Toronto 6
Araucária 5
Bogotá 5
Catania 5
Chieti 5
Gurgaon 5
Indiana 5
Nuremberg 5
Paris 5
Verona 5
Accra 4
Atlanta 4
Bern 4
Totale 5.089
Salva come PNG Salva come JPEG
Nome #
Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count 268
More, more, more: Reducing thrombosis in acute coronary syndromes beyond dual antiplatelet therapy-current data and future directions 251
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 230
Mean Platelet Volume, Platelet Distribution Width, and Platelet Count in Type 2 Diabetes Mellitus, Impaired Fasting Glucose, and Metabolic Syndrome: systematic review and meta-analysis 159
Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study. 145
Obesity is associated with in vivo platelet activation and impaired responsiveness to once-daily, low-dose aspirin 143
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 134
Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study 123
Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors 121
Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13. A new prothrombotic mechanism associated with oxidative stress 118
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target 117
In vivo platelet activation and aspirin responsiveness in type 1 diabetes mellitus 117
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 111
Abnormal megakaryopoiesis and platelet function in cyclooxygenase-2-deficient mice 108
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 108
Pseudo-acquired vWD in essential thrombocythemia: the role of platelets 105
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes 105
Effect of fibrinogen concentration on the velocity of platelet aggregation. 104
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy 101
Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysis 99
Increased thromboxane biosynthesis in essential thrombocythemia. 89
Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia 87
Safety of Antithrombotic Agents in Elderly Patients with Acute Coronary Syndromes 87
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 87
Drug insight: aspirin resistance- fact or fashion 84
Aspirin, stroke and drug-drug interactions 84
Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis 83
Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo" 82
Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis. 80
Fechtner syndrome: report of a third family and literature review 79
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis 79
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: A joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) 79
Type 2 Diabetes, Obesity, and Aspirin Responsiveness* 76
Aspirin: promise and resistance in the new millennium. 74
Homocysteinemia is inversely correlated with platelet count and inversely correlated with sE-and sP-selectin levels in females homozygous for C677T methylenetetrahydrofolate reductase 74
In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythaemia 74
Farmaci antipiastinici 73
The future of antiplatelet therapy in cardiovascular disease 72
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 71
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 71
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response 69
Bleeding and thrombosis in myeloproliferative disorders: mechanisms and treatment 67
Another family with IGPS 67
Identifying determinants of variability to tailor aspirin therapy 67
Inherited macrothrombocytopenia with distinctive platelet ultrastructural and functional features 66
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy 65
Platelet progenitors: the hidden drug target 65
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation 65
Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector. 64
In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythemia 64
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 64
Stability of urinary thromboxane A2 metabolites and adaptation of the extraction method to small urine volume 63
Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter 62
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 62
Platelet indices and glucose control in type 1 and type 2 diabetes mellitus: A case-control study 61
Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects 60
Aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: A new perspective 60
Familial autoimmune myasthenia gravis with different pathogenetic antibodies 59
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis 59
Eicosanoid biosynthesis and metabolism in myeloproliferative disorders 58
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 57
Determinants of the interindividual variability in response to antiplatelet drugs. 57
Wiskott-Aldrich syndrome: report of an autosomal dominant variant 57
Antithrombotic therapy in diabetes: which, when, and for how long? 57
Successful pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation. 56
MYH9 spectrum of autosomal-dominant giant platelet syndromes: unexpected association with fibulin-1 variant-D inactivation 56
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis 56
Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease 56
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 56
The linkage between binding of the C-terminal domain of hirudin and amidase activity in human alpha-thrombin 55
Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter 55
Increased thromboxane metabolites excretion in liver cirrhosis. 54
Nonsteroidal antiinflammatory drugs: past, present and future 53
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) 53
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis 53
Fibrinogen-elongated gamma chain inhibits thrombin-induced platelet response, hindering the interaction with different receptors 52
A case of coloboma in a newborn to a woman taking mycophenolate mofetil in pregnancy after kidney transplantation. 52
Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Acute Cardiovascular Care Association (ACCA), Association of Cardiovascular Nursing and Allied Professions (ACNAP), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Council on Valvular Heart Diseases (VHD), Council on Hypertension (CHT), Council of Cardio-Oncology (CCO), Working Group (WG) Aorta and Peripheral Vascular Diseases, WG e-Cardiology, WG Thrombosis, of the European Society of Cardiology, European Primary Care Cardiology Society (EPCCS) 52
Unmet clinical needs of antithrombotic treatment in Philadelphia negative myeloproliferative neoplasms 51
Autosomal dominant giant platelet syndrome: a hint of the same genetic defect as in Fetchner syndrome owing to a similar genetic linkage to chromosome 22q11-13 50
Platelet activation and inhibition in polycythemia vera and essential thrombocythemia. 50
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 50
Interindividual Variability in response to aspirin and P2Y12 blockers in patients at high cardiovascular risk-the state of the evidence 49
Should patients with osteoarthritis be treated with COX2 inhibitors rather than traditional NSAIDs? 49
Aspirin and Other COX-1 Inhibitors 48
Farmaci Antipiastrinici 48
The Key Contribution Of Platelet And Vascular Arachidonic Acid Metabolism To The Pathophysiology Of Atherothrombosis 48
Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus. 47
Role of prostacyclin in the cardiovascular response to thromboxane A2 47
The lifespan determinant p66sch drives obesity-induced oxidative stress, mitochondrial dysfunction and vascular inflammation 47
Pathophysiology of Thrombosis in Peripheral Artery Disease 47
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a Joint Position Paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI) 47
LACK OF AN ASSOCIATION BETWEEN INHERITED THROMBOPHILIC RISK FACTORS AND IDIOPATIC SUDDEN SENSORINEURAL HEARING LOSS IN ITALIAN PATIENTS 47
MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness 45
genetic deletion of P66 (sch) protects against obesity induced mithocondrial dysfunction, oxidative stress and vascular inflammation 45
Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia 45
Variability in the Responsiveness to Low-Dose Aspirin: Pharmacological and Disease-Related Mechanisms. 44
Effect of ketorolac, ketoprofen and nefopam on platelet function 44
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome 44
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: A joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA) 44
Totale 7.642
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.773
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.773
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020664 0 0 0 0 61 84 97 41 51 74 138 118
2020/20211.038 43 113 24 108 149 54 115 27 140 50 181 34
2021/20221.145 157 93 13 73 86 32 32 187 44 33 175 220
2022/20232.133 313 301 176 241 175 237 75 172 257 43 95 48
2023/20241.357 43 348 42 179 80 132 97 29 28 69 136 174
2024/2025559 61 54 196 89 159 0 0 0 0 0 0 0
Totale 9.586